Dyne Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Dyne Therapeutics (Nasdaq:DYN) announced participation in several investor conferences focused on healthcare in May and June 2026.

Management will join fireside chats at the RBC Capital Markets Global Healthcare Conference on May 20 and the Jefferies Global Healthcare Conference on June 3 in New York, plus investor meetings at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9 in Miami.

Live webcasts and 90-day replays of the fireside chats will be available in the Investors & Media section of Dyne’s website.

News Market Reaction – DYN

+0.38%

+0.38% Session close to close

In the May 13 session, DYN gained 0.38%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WALTHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that management is scheduled to participate in the following upcoming investor conferences:

• 2026 RBC Capital Markets Global Healthcare Conference, fireside chat on Wednesday, May 20, 2026 at 11:00 a.m. ET in New York, NY
• 2026 Jefferies Global Healthcare Conference, fireside chat on Wednesday, June 3, 2026 at 9:55 a.m. ET in New York, NY
• Goldman Sachs 47^th Annual Global Healthcare Conference 2026, hosting meetings on Tuesday, June 9, 2026 in Miami, FL
  

A live webcast of each fireside chat will be available in the Investors & Media section of Dyne’s website at https://investors.dyne-tx.com/news-and-events/events-and-presentations and a replay will be accessible for 90 days.

About Dyne Therapeutics

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.

Contacts:

Investors
Mia Tobias
ir@dyne-tx.com
781-317-0353

Media
Stacy Nartker 
snartker@dyne-tx.com
781-317-1938

FAQ

What investor conferences will Dyne Therapeutics (DYN) attend in May and June 2026?

Dyne Therapeutics will attend the 2026 RBC Capital Markets Global Healthcare Conference, the 2026 Jefferies Global Healthcare Conference, and Goldman Sachs 47th Annual Global Healthcare Conference 2026, offering investors multiple opportunities to hear from management.

When is Dyne Therapeutics' fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference?

Dyne Therapeutics' fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference is scheduled for Wednesday, May 20, 2026, at 11:00 a.m. ET in New York, giving investors a set time to follow live commentary.

What time is Dyne Therapeutics' fireside chat at the 2026 Jefferies Global Healthcare Conference?

Dyne Therapeutics' fireside chat at the 2026 Jefferies Global Healthcare Conference is on Wednesday, June 3, 2026, at 9:55 a.m. ET in New York, providing another forum for investor updates.

How can investors access the Dyne Therapeutics (DYN) webcasts for the May and June 2026 conferences?

Investors can access live webcasts of each Dyne Therapeutics fireside chat in the Investors & Media section of Dyne’s website, with on-demand replay available for 90 days after each event.

Will replays of Dyne Therapeutics' 2026 investor conference presentations be available?

Yes, Dyne Therapeutics stated that replays of each fireside chat will be accessible for 90 days in the Investors & Media section of its website, allowing investors to watch after the live events.

Where is the Goldman Sachs 47th Annual Global Healthcare Conference 2026 with Dyne Therapeutics being held?

Dyne Therapeutics will host investor meetings at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 on Tuesday, June 9, 2026, in Miami, Florida, offering in-person engagement with the investment community.